PSMF: The Foundation of a Strong Pharmacovigilance System
Pharmacovigilance System Master File Management with Clarity and Confidence
The Pharmacovigilance System Master File is a cornerstone of regulatory compliance. It must accurately reflect the pharmacovigilance system of the marketing authorization holder while remaining current, complete, and inspection ready at all times. APCER supports organizations with structured PSMF services that simplify this responsibility and ensure alignment with global pharmacovigilance requirements.
Our experts manage the creation, maintenance, and periodic updates of the PSMF through well defined processes and close collaboration with internal stakeholders. This structured approach ensures that the PSMF remains accurate, comprehensive, and ready for regulatory review whenever required.
Managing the Complexity of PSMF Compliance
The ongoing management of the PSMF presents several operational challenges that organizations must address to ensure regulatory compliance and inspection readiness.
The APCER Advantage in PSMF Management
APCER brings together pharmacovigilance expertise, structured processes, and global regulatory insight to ensure that your PSMF remains accurate, current, and fully aligned with evolving compliance requirements.
- Seamless Inspections with Confidence Enjoy peace of mind with a flawless inspection record and comprehensive oversight of all pharmacovigilance processes, ensuring your compliance is always on point.
- Timely Compliance Made Simple Stay ahead of regulatory timelines with PSMF maintenance that includes periodic updates aligned to a predefined annual calendar, ensuring your PSMF is always current and inspection-ready.
- Global Scalability with Regulatory Expertise Benefit from PSMF creation and maintenance tailored to meet the latest pharmacovigilance requirements, whether for global or country-specific needs (EU, UK, ROW).
- Accurate and Centralized Documentation Rely on a centralized team that consolidates data from multiple tools and stakeholders, ensuring your PSMF is accurate, up-to-date, and fully documented at all times.
Enabling compliance through strong PSMF management & QPPV oversight
A global pharmaceutical client maintained uninterrupted compliance by leveraging APCER’s robust PSMF management, up-to-date documentation, and enhanced transparency across their pharmacovigilance system.
Quality and Compliance
- Version-controlled SOPs
- Role-based structured training
- End-to-end Deviation and CAPA lifecycle management
- Risk-based audit program
- electronic Quality Management System (eQMS) and electronic Learning Management System (eLMS)
Ready for a partner who matches your ambition?
With APCER, you gain more than a service provider—you secure a champion for compliance, a catalyst for growth, and a steadfast ally dedicated to protecting patients and your reputation.
Real Results. Real Trust.
Real Stories
Sincerely thank you for all the effort, thoroughness and professionalism that went through conducting and reporting on this FDA PADER Gap Analysis as we now embark on our journey towards documentation and process improvement to ensure readiness for an actual inspection.
Director, Drug Safety and Medical Information
Canada-based global pharma
The APCER Pharmacovigilance team demonstrated exceptional collaboration and inspection readiness during FDA PADE Inspection. The accuracy, consistency, and completeness of expedited reports, reconciliations, and aggregate safety documentation clearly reflected strong teamwork and compliance across all deliverables.
VP, Regulatory and Quality
US-based biopharma
With all the transformation and rapid growth happening, having a reliable PV/med info partner like the APCER group has truly been invaluable—it’s made a real difference in helping us navigate the complexities and keep challenges to a minimum.
VP, Medical Affairs
US-based specialty pharma
... the preparation and support for our BPD Type 2a meeting were a strong example of APCER’s commitment and effectiveness and instrumental in keeping us aligned and confident in our regulatory strategy. We have greatly valued the team’s responsiveness, collaborative approach, and sound regulatory judgment.
Chief Medical Officer
A clinical-stage biopharma
Phase 1 completion is an achievement that demonstrates APCER's scalability, flexibility, and operational readiness. It reflects exceptional cross-functional collaboration.
Associate Director, IT Business Partner
Japan-headquartered, global healthcare company
I want to sincerely appreciate all the great work Team APCER has been doing. Their strong attention to detail, agility in handling tasks, and consistent respect for timelines have been truly impressive.
Associate Director, Safety Physician
Japan-headquartered, global healthcare company
Deep gratitude to entire APCER team for their efforts in working hard to complete the cases. While the system outage was well beyond their control, their strong work to make up for the lost time ensured that we're able to maintain compliance.
Associate Director, Pharmacovigilance Operations
US-based biotech
Sincere appreciation for APCER's partnership and dedicated service. The team’s commitment, adaptability, and collaborative approach have been instrumental in supporting our pharmacovigilance operations through both high and low volumes of activity.
Sr.Director, PV Operations-Global Case Management
US-based biotech
I’ve greatly valued APCER’s commitment to excellence. Their contributions have played a key role in helping us uphold our compliance standards and achieve strong performance across key metrics, including timely deviation closure, audit readiness, and quality of deliverables.
Sr. Director PV Ops – Pharmacovigilance Center of Excellence
US-based biotech
